Showing results (2351-2360 of 6,812) with videos related to

Sort By:
Pageof 682
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responsesT Utsunomiya, M Kobayashi, M Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic propertiesK M Pollard, D L Pearson, M Blüthner, et al.
IEEE Transactions on Bio-Medical Engineering|August 16, 2000
Distributed computing for membrane-based modeling of action potential propagationD Porras, J M Rogers, W M Smith, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|December 29, 2000
[Biological properties of T6S cells, a clone of burn-associated type 2 T cells]N Nakajima, T Utsunomiya, M Kobayashi, et al.
Antiviral Research|May 1, 1994
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replicationM Nokta, M D Tolpin, P I Nadler, et al.
British Journal of Anaesthesia|January 1, 1995
Pulmonary function and head lift during spontaneous recovery from pipecuronium neuromuscular blockN El Mikatti, A Wilson, B J Pollard, et al.
Journal of Cell Science|November 1, 1994
Differential localization of myosin-II isozymes in human cultured cells and blood cellsP Maupin, C L Phillips, R S Adelstein, et al.
Molecular and Cellular Neurosciences|November 17, 2009
The effect of exposure time to interferon-gamma on MHC molecule expression in cultures of human dorsal root gangliaP J Armati, M Karakotchian, J D Pollard, et al.
The Journal of Biological Chemistry|October 5, 1986
Crystallization of Acanthamoeba profilin-IK A Magnus, E E Lattman, M Sato, et al.
Vaccine|October 16, 2025
A statistical method for evaluating vaccine-induced immune correlates of protection against infection and disease progression: application to the ChAdOx1-S nCoV-19 phase 3 trialLucy R Williams, Merryn Voysey, Andrew J Pollard, et al.
Pageof 682